CH625787A5 - - Google Patents

Download PDF

Info

Publication number
CH625787A5
CH625787A5 CH1151775A CH1151775A CH625787A5 CH 625787 A5 CH625787 A5 CH 625787A5 CH 1151775 A CH1151775 A CH 1151775A CH 1151775 A CH1151775 A CH 1151775A CH 625787 A5 CH625787 A5 CH 625787A5
Authority
CH
Switzerland
Prior art keywords
formula
carbon atoms
group
compounds
piperidine
Prior art date
Application number
CH1151775A
Other languages
German (de)
English (en)
Inventor
Dennis Michael Zimmerman
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of CH625787A5 publication Critical patent/CH625787A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/20—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CH1151775A 1974-09-06 1975-09-05 CH625787A5 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US50358174A 1974-09-06 1974-09-06

Publications (1)

Publication Number Publication Date
CH625787A5 true CH625787A5 (fr) 1981-10-15

Family

ID=24002675

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1151775A CH625787A5 (fr) 1974-09-06 1975-09-05

Country Status (27)

Country Link
US (1) US4081450A (fr)
JP (3) JPS5929588B2 (fr)
AR (1) AR206937A1 (fr)
AT (1) AT350567B (fr)
BE (1) BE833044A (fr)
BG (2) BG24802A3 (fr)
CA (1) CA1069901A (fr)
CH (1) CH625787A5 (fr)
CS (1) CS188237B2 (fr)
DD (1) DD121636A5 (fr)
DE (1) DE2539452A1 (fr)
DK (1) DK153397C (fr)
ES (1) ES440771A1 (fr)
FR (2) FR2283679A1 (fr)
GB (1) GB1525584A (fr)
HU (1) HU173057B (fr)
IE (1) IE41610B1 (fr)
IL (1) IL48003A (fr)
NL (1) NL7510535A (fr)
NZ (1) NZ178501A (fr)
PH (2) PH12618A (fr)
PL (3) PL100438B1 (fr)
RO (1) RO68142A (fr)
SE (1) SE425489B (fr)
SU (2) SU629875A3 (fr)
YU (2) YU221675A (fr)
ZA (1) ZA755614B (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4284635A (en) * 1978-11-29 1981-08-18 Eli Lilly And Company Analgesic 1,2,4,5-tetra-alkyl-4-arylpiperidines
FR2451368A1 (fr) * 1979-03-12 1980-10-10 Lilly Co Eli Phenylmorphanes, intermediaires et procedes de synthese, et leur utilisation therapeutique
ZA813127B (en) * 1980-05-13 1982-05-26 May & Baker Ltd A new phenylpropargylamine derivative
CH646696A5 (de) 1980-11-28 1984-12-14 Sandoz Ag Dibenzazepine, ihre herstellung und verwendung.
FR2518093A2 (fr) * 1980-12-15 1983-06-17 Roussel Uclaf Nouveaux derives de l'hydroxyphenyl tetrahydropyridine, leurs sels, procede et intermediaires de preparation, application a titre de medicaments et compositions les renfermant
US4931558A (en) * 1983-09-21 1990-06-05 Eli Lilly And Company Processes for preparing intermediates of picenadol
US4581456A (en) * 1983-09-21 1986-04-08 Eli Lilly And Company Processes for preparing picenadol precursors and novel intermediates thereof
US4678638A (en) * 1985-07-24 1987-07-07 Petrolite Corporation Highly branched amino hexahydropyridines
ES2058265T3 (es) * 1987-04-16 1994-11-01 Lilly Co Eli Piperidinas antagonistas de opiaceos.
US5319087A (en) * 1987-04-16 1994-06-07 Eli Lilly And Company Piperidine opioid antagonists
EP0299549A3 (fr) * 1987-07-09 1989-02-08 Duphar International Research B.V 3,5-Dialkyl-3-phényl-pipéridines avec une activité antagoniste des opiates
US5250542A (en) * 1991-03-29 1993-10-05 Eli Lilly And Company Peripherally selective piperidine carboxylate opioid antagonists
US5270328A (en) * 1991-03-29 1993-12-14 Eli Lilly And Company Peripherally selective piperidine opioid antagonists
US5159081A (en) * 1991-03-29 1992-10-27 Eli Lilly And Company Intermediates of peripherally selective n-carbonyl-3,4,4-trisubstituted piperidine opioid antagonists
ZA9610741B (en) 1995-12-22 1997-06-24 Warner Lambert Co 4-Substituted piperidine analogs and their use as subtype selective nmda receptor antagonists
GB9725114D0 (en) * 1997-11-28 1998-01-28 Pfizer Ltd Treatment of pruritus
GB9810671D0 (en) * 1998-05-18 1998-07-15 Pfizer Ltd Anti-pruritic agents
GB9912415D0 (en) 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
GB9912417D0 (en) 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
GB9912410D0 (en) 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
GB9912416D0 (en) 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
GB9912413D0 (en) 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
GB9912411D0 (en) * 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
US7045527B2 (en) * 2002-09-24 2006-05-16 Amgen Inc. Piperidine derivatives
US10519111B2 (en) 2013-07-15 2019-12-31 Coral Sunscreen Pty Ltd UV absorbing compounds, compositions comprising same and uses thereof
BR112016000844A8 (pt) * 2013-07-15 2020-01-07 Coral Sunscreen Pty Ltd compostos absorvedores de uv, composições que compreendem os mesmos, usos destes e método de proteger uma superfície ou tecido dos raios uv

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD87036A (fr) *
US2892842A (en) * 1959-06-30 Their preparation
US1915334A (en) * 1930-10-16 1933-06-27 Du Pont Fluosilicate of organic heterocyclic bases and process of making it
US2075359A (en) * 1930-10-16 1937-03-30 Du Pont Insecticide
US3080372A (en) * 1960-03-25 1963-03-05 Res Lab Dr C Janssen 1-aroylalkyl-4-arylpiperidine derivatives
US3936468A (en) * 1969-10-27 1976-02-03 Sumitomo Chemical Company, Ltd. Phenylbutanol derivatives

Also Published As

Publication number Publication date
YU221675A (en) 1982-02-28
DD121636A5 (fr) 1976-08-12
YU233681A (en) 1982-02-28
ES440771A1 (es) 1977-04-01
IL48003A0 (en) 1975-11-25
GB1525584A (en) 1978-09-20
IE41610L (en) 1976-03-06
HU173057B (hu) 1979-02-28
JPS6026782B2 (ja) 1985-06-25
SE425489B (sv) 1982-10-04
DK153397C (da) 1988-12-05
FR2299337B1 (fr) 1979-01-19
FR2299337A1 (fr) 1976-08-27
BG24802A3 (en) 1978-05-12
AT350567B (de) 1979-06-11
BE833044A (fr) 1976-03-03
PL100438B1 (pl) 1978-10-31
PH12618A (en) 1979-07-05
SU621316A3 (ru) 1978-08-25
AR206937A1 (es) 1976-08-31
US4081450A (en) 1978-03-28
JPS5148670A (fr) 1976-04-26
NL7510535A (nl) 1976-03-09
NZ178501A (en) 1978-09-20
BG24950A3 (en) 1978-06-15
JPS5916875A (ja) 1984-01-28
JPS5929588B2 (ja) 1984-07-21
PH14016A (en) 1980-12-08
JPS6051174A (ja) 1985-03-22
DK397575A (da) 1976-03-07
PL108465B1 (en) 1980-04-30
ATA685275A (de) 1978-11-15
RO68142A (fr) 1981-08-30
SU629875A3 (ru) 1978-10-25
DK153397B (da) 1988-07-11
ZA755614B (en) 1977-04-27
IL48003A (en) 1981-01-30
CA1069901A (fr) 1980-01-15
FR2283679A1 (fr) 1976-04-02
DE2539452A1 (de) 1976-03-18
IE41610B1 (en) 1980-02-13
JPS6012350B2 (ja) 1985-04-01
CS188237B2 (en) 1979-02-28
AU8431375A (en) 1977-03-03
FR2283679B1 (fr) 1979-09-14
PL117501B1 (en) 1981-08-31
SE7509640L (sv) 1976-03-08

Similar Documents

Publication Publication Date Title
CH625787A5 (fr)
DE60030883T2 (de) Verfahren zur herstellung von alfentanil, sufentanil und remifentanil
US4115400A (en) 1-Azoniabicyclo[3.1.0]hexanes
EP0241003B1 (fr) Dérivés de 4H-1-benzopyran-4-one, procédé pour leur préparation et leur utilisation comme médicaments
DE69103206T2 (de) Neue Derivate des Aminopiperidins, Aminopyrrolidins und des Aminoperhydroazepins, Verfahren zur Herstellung und diese enthaltende Arzneimittel.
DE2243961C2 (fr)
DE69709938T2 (de) N-benzylpiperidin- und tetrahydropyridin-derivate
DE69629831T2 (de) Herstellungsverfahren fuer piperidinderivate
DE2610228A1 (de) N-(4-piperidinyl)-n-phenylamide und -carbamate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
US4191771A (en) Analgesic method using 1,3,4-trisubstituted-4-arylpiperidines
DE2002840A1 (de) 2,3,5-trisubstit,-2'-Hydroxy-6,7-benzomorphane und Verfahren zu deren Herstellung
DE2819210A1 (de) 4-aminomethyl-1-(3,3,3-triarylpropyl)-4-arylpiperidin und dessen derivate
DD147537A5 (de) Verfahren zur herstellung von 1,2,4,5-tetra-alkyl-4-aryl-piperidinen
EP0004358B1 (fr) N-oxacyclylalkylpipéridines, procédé pour leur préparation, compositions pharmaceutiques contenant ces composés
DE2434687A1 (de) Neue analgetika und verfahren zu ihrer herstellung
CH637934A5 (de) Verfahren zur herstellung neuer derivate von perhydro-aza-heterocyclen.
DE69710909T2 (de) Substituierte tetrahydropyridinderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
DE2264668A1 (de) Propenylaminderivate und verfahren zu dereb herstellung
DD141156A5 (de) Verfahren zur herstellung von 4a-aryl-octahydro-1h-2-pyrindinen
EP0064685A1 (fr) Dibenzo(de,g)quinolines, leurs procédés de préparation et les médicaments les contenant
US4175197A (en) 1,3,4-Trisubstituted-4-aryl-1,4,5,6-tetra-hydropyridines
DE1620746A1 (de) Verfahren zur Herstellung von Phenothiazin-Derivaten
DE2456246A1 (de) Neue benzothiophene und verfahren zu ihrer herstellung
CH644364A5 (de) 4-(naphthalinyloxy)piperidin-derivate.
DE69730615T2 (de) Verfahren zur herstellung eines tetrahydropyridinderivates

Legal Events

Date Code Title Description
PL Patent ceased